Promising News on Vaginal Microbicides
Centers for Disease Control and Prevention (CDC)
Promising News on Vaginal Microbicides
Use of a tenofovir-based vaginal gel decreased HIV infections in women in a trial in South Africa. The study also showed that the microbicide significantly reduced the risk of genital herpes (HSV-2), which is common in developing countries and in the United States, and facilitates HIV transmission.
Visit the
NCHHSTP Newsroom to read more on these important updates.